カテゴリ： GlobalData, 医療/バイオ

ループス腎炎治療薬の世界市場：治験レビュー

◆英語タイトル：Lupus Nephritis Global Clinical Trials Review, H2, 2019
◆商品コード：GDT20FB0049
◆発行会社（リサーチ会社）：GlobalData
◆発行日：2019年12月
◆ページ数：173
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥275,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD5,000 ⇒換算￥550,000見積依頼/購入/質問フォーム
Enterprisewide Price（複数事業所内共有可）USD7,500 ⇒換算￥825,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

 【レポートの概要】

Lupus Nephritis Global Clinical Trials Review, H2, 2019
Summary

GlobalData’s clinical trial report, “Lupus Nephritis Global Clinical Trials Review, H2, 2019″ provides an overview of Lupus Nephritis clinical trials scenario. This report provides top line data relating to the clinical trials on Lupus Nephritis . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
List of Tables 4
List of Figures 5
Report Guidance 6
GlobalData Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by G7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 17
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Lupus Nephritis to Immunology Clinical Trials 20
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Clinical Trials by End Point Status 28
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Lupus Nephritis Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on Lupus Nephritis 36
Nov 11, 2019: Genentech’s Gazyva (obinutuzumab), in Combination With Standard of Care, More Than Doubles the Percentage of Lupus Nephritis Patients Achieving Complete Renal Response, Compared To Standard of Care Alone 36
Nov 08, 2019: Apellis Presents First Data on APL-2 in C3 Glomerulopathy at ASN Kidney Week 36
Nov 06, 2019: Equillium to present new data and insights on the CD6-ALCAM pathway in Lupus Nephritis at ACR 2019 37
Oct 16, 2019: Aurinia reports last patient study visit in Aurora phase 3 lupus nephritis study and provides update on ATM facility 37
Oct 11, 2019: Apellis to present data on APL-2 in complement 3 Glomerulopathy at ASN Kidney Week 2019 38
Oct 01, 2019: Equillium Announces Initiation of the EQUALISE Phase 1b Clinical Trial of Itolizumab for Patients with Lupus Nephritis and Provides Business Update 38
Sep 25, 2019: Omeros announces publication of study showing that inhibition of MASP-2, the key enzyme of the complement system’s Lectin Pathway, protects against renal injury caused by Proteinuria 39
Sep 19, 2019: Roche receives FDA breakthrough status for lupus nephritis drug 39
Clinical Trial Profile Snapshots 40
Appendix 176
Abbreviations 176
Definitions 176
Research Methodology 177
Secondary Research 177
About GlobalData 178
Contact Us 178
Source 179

List of Tables
Lupus Nephritis Therapeutics, Global, Clinical Trials by Region, 2019* 8
Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 10
Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2019* 12
Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2019* 13
Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries, 2019* 14
Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2019* 15
Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2019* 16
Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2019* 17
Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2019* 20
Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 23
Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase, 2019* 24
Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Phase 2019* 25
Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 27
Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2019* 30
Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 32
Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 34
Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35

List of Figures
Lupus Nephritis Therapeutics, Global, Clinical Trials by Region (%), 2019* 8
Lupus Nephritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2019* 9
Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2019* 11
Lupus Nephritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2019* 12
Lupus Nephritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2019* 13
Lupus Nephritis Therapeutics Clinical Trials, North America, Top Countries (%), 2019* 14
Lupus Nephritis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2019* 15
Lupus Nephritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2019* 16
Proportion of Lupus Nephritis to Immunology Clinical Trials, G7 Countries (%), 2019* 17
Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2019* 18
Lupus Nephritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2019* 19
Proportion of Lupus Nephritis to Immunology Clinical Trials, E7 Countries (%), 2019* 20
Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2019* 21
Lupus Nephritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2019* 22
Lupus Nephritis Therapeutics, Global, Clinical Trials by Phase (%), 2019* 24
Lupus Nephritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2019* 25
Lupus Nephritis Therapeutics, Global, Clinical Trials by Trial Status, 2019* 26
Lupus Nephritis Therapeutics Clinical Trials, Global, by End Point Status, 2019* 28
Lupus Nephritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018 29
Lupus Nephritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2019* 30
Lupus Nephritis Therapeutics Clinical Trials, Global, Key Sponsors, 2019* 31
Lupus Nephritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2019* 33
Lupus Nephritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2019* 35
GlobalData Methodology 177

【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[ループス腎炎治療薬の世界市場：治験レビュー]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 自閉症治療薬の世界市場：治験レビュー
    GDT20FB0029 / GlobalData / 2019年12月 / ...Autism Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Autism Global Clinical Trials Review, H2, 2019" provides an overview of Autism clinical trials scenario. This report provides top line data relating to the clinical trials on Autism Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  2. 直腸がん治療薬の世界市場：治験レビュー
    GDT20FB0065 / GlobalData / 2019年12月 / ...Rectal Cancer Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Rectal Cancer Global Clinical Trials Review, H2, 2019" provides an overview of Rectal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Rectal Cancer Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  3. 開放隅角緑内障治療薬の世界市場：治験レビュー
    GDT20FB0115 / GlobalData / 2020年1月 / ...Open-Angle Glaucoma Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Open-Angle Glaucoma Global Clinical Trials Review, H1, 2020" provides an overview of Open-Angle Glaucoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Open-Angle Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  4. アテローム性動脈硬化治療薬の世界市場：治験レビュー
    GDT20FB0063 / GlobalData / 2019年12月 / ...Atherosclerosis Global Clinical Trials Review, H2, 2019.... Summary GlobalData's clinical trial report, “Atherosclerosis Global Clinical Trials Review, H2, 2019" provides an overview of Atherosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Atherosclerosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  5. 便秘治療薬の世界市場：治験レビュー
    GDT20FB0116 / GlobalData / 2020年1月 / ...Constipation Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Constipation Global Clinical Trials Review, H1, 2020" provides an overview of Constipation Clinical trials scenario. This report provides top line data relating to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  6. 勃起不全治療薬の世界市場：治験レビュー
    GDT20FB0120 / GlobalData / 2020年1月 / ...Erectile Dysfunction Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Erectile Dysfunction Global Clinical Trials Review, H1, 2020" provides an overview of Erectile Dysfunction Clinical trials scenario. This report provides top line data relating to the clinical trials on Erectile Dysfunction. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  7. 高脂血症治療薬の世界市場：治験レビュー
    GDT20FB0099 / GlobalData / 2020年1月 / ...Hyperlipidemia Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Hyperlipidemia Global Clinical Trials Review, H1, 2020" provides an overview of Hyperlipidemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperlipidemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  8. 膀胱がん治療薬の世界市場：治験レビュー
    GDT20FB0059 / GlobalData / 2019年12月 / ...Bladder Cancer Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Bladder Cancer Global Clinical Trials Review, H2, 2019" provides an overview of Bladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData...
  9. 高尿酸血症治療薬の世界市場：治験レビュー
    GDT20FB0121 / GlobalData / 2020年1月 / ...Hyperuricemia Global Clinical Trials Review, H1, 2020 Summary GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, H1, 2020" provides an overview of Hyperuricemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are...
  10. 急性心不全治療薬の世界市場：治験レビュー
    GDT20FB0069 / GlobalData / 2019年12月 / ...Acute Heart Failure Global Clinical Trials Review, H2, 2019 Summary GlobalData's clinical trial report, “Acute Heart Failure Global Clinical Trials Review, H2, 2019" provides an overview of Acute Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Heart Failure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆